The role of TNFR2 in ameliorating progressive encephalomyelitis
TNFR2 在改善进行性脑脊髓炎中的作用
基本信息
- 批准号:10542764
- 负责人:
- 金额:$ 37.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AllelesAnimalsAnti-Inflammatory AgentsAstrocytesAutoimmune DiseasesAutomobile DrivingBLR1 geneBiologicalBiological AssayCXCL13 geneCell physiologyCellsCerebrospinal FluidChronicDemyelinationsDevelopmentDiseaseDisease ProgressionEncephalomyelitisExperimental Autoimmune EncephalomyelitisFOXP3 geneFluorescent in Situ HybridizationGene ExpressionGoalsHumanImmunologicsImpairmentInflammatoryKnockout MiceKnowledgeLesionLeukocytesLipid PeroxidationMediatingMethodsMicrogliaMigration AssayModelingMolecularMultiple SclerosisMusNeurogliaNeuronsOligodendrogliaOxidative StressPathogenicityPatientsPharmaceutical PreparationsPlayPopulationProcessPropertyRNAReceptors, Tumor Necrosis Factor, Type IIRegulatory T-LymphocyteReportingRoleSignal TransductionT cell responseT-LymphocyteTNF geneTNFRSF1A geneTNFRSF1B geneTestingTransgenic MiceWorkastrogliosisblocking factorcell typecytokineinnovationmouse modelmultiple sclerosis patientmultiple sclerosis treatmentneuroinflammationneuroprotectionnovel strategiespre-clinicalpreventrecruitremyelinationrepairedrestraintsingle moleculesingle-cell RNA sequencingwhite matter
项目摘要
The mechanisms driving progressive multiple sclerosis (MS) remain enigmatic. Progression of MS correlates with the
expression of the cytokine tumor necrosis factor (TNF) in cerebrospinal fluid of patients, suggesting that TNF plays a
key role in the disease process. Thus, targeting TNF was suggested as an attractive therapy for MS. Surprisingly, however,
TNF-blocking drugs with proven efficacy in other autoimmune diseases triggered onset and exacerbations of MS, which
provided evidence that TNF can also contribute to CNS protection and repair. Subsequent work showed that pathogenic
TNF effects in EAE are mediated via TNF receptor (TNFR) 1, whereas TNFR2 signaling ameliorates disease and reduces
demyelination. TNFR2 is expressed by different cell types in the CNS, including microglia and oligodendrocytes, and its
expression by these cells can promote repair and remyelination. Likewise, astrocytes can express TNFR2, but the role of
TNFR2 expressed by astrocytes for MS/EAE progression remains unresolved. Astrocytes with pathogenic (A1) or
neuroprotective/anti-inflammatory properties (A2) have been described; however, the mechanisms orchestrating
detrimental versus beneficial astrocyte functions are still not fully understood. We have obtained exciting preliminary
results supporting a central role for astrocyte TNFR2 in curtailing EAE progression by investigating the role of
TNFR2 in a “humanized” transgenic mouse model expressing the human MS-associated MHC II allele HLA-DR2b and
lacking the expression of TNFR2 molecules, herein called DR2bΔR2 mice. This model provided evidence that the HLA-
DR2b molecule favored Th17 development, while impairing Foxp3+ Treg cell formation. Importantly, we observed that
DR2bΔR2 mice developed progressive EAE and astrogliosis when CNS resident cells were TNFR2 deficient.
Moreover, in DR2bΔR2 animals with EAE, astrocytes showed increased expression of pro-inflammatory cytokines and
increased expression of CXCR5. Additionally, CXCL13 was upregulated in the CNS of these mice in line with previous
reports that CNS expression of CXCL13 aggravates EAE and promotes chronic white matter lesions that is not
dependent on recruitment of CXCR5+ leukocytes from the periphery, and that CXCL13 expressed by damaged neurons can
activate astrocytes. Moreover, we observed a striking dichotomy in the expression of TNFR2 between astrocyte populations
in DR2b mice with EAE, suggesting that TNFR2 expression may favor astrocyte A2 versus A1 subpopulations. Thus,
our proposal will test the central hypothesis that TNFR2 signaling in astrocytes curtails progression of neuroinflammation
by restraining pathogenic and promoting protective astrocyte functions. We will test our hypothesis by (1) determining the
role of TNFR2 for curtailing pathogenic astrocyte effector functions and preventing EAE progression; and (2) determining
the role of TNFR2-regulated CXCL13/CXCR5 signaling for chronic astrocyte activation and function in progressive EAE
in DR2bΔR2 mice. We will accomplish the objectives of this proposal by applying innovative new approaches including
our progressive EAE model, developing astrocyte-specific TNFR2 and CXCR5 knockout mice, and innovative
immunological and molecular biological methods, including single-cell RNA-seq and RNAScope.
导致进行性多发性硬化症(MS)的机制仍然是个谜。多发性硬化症的进展与
细胞因子肿瘤坏死因子在脑脊液中的表达,提示肿瘤坏死因子在脑脊液中起重要作用
在疾病过程中起关键作用。因此,靶向肿瘤坏死因子被认为是一种对多发性硬化症有吸引力的治疗方法,然而令人惊讶的是,
在其他自身免疫性疾病中被证明有效的肿瘤坏死因子阻断药物会引发多发性硬化症的发病和恶化,
提供的证据表明,肿瘤坏死因子也有助于中枢神经系统的保护和修复。随后的研究表明,致病的
在EAE中,肿瘤坏死因子的作用是通过肿瘤坏死因子受体(TNFR)1介导的,而TNFR2信号可以改善疾病,减少
脱髓鞘。TNFR2在中枢神经系统中由不同类型的细胞表达,包括小胶质细胞和少突胶质细胞,其
这些细胞的表达可以促进修复和重新髓鞘形成。同样,星形胶质细胞可以表达TNFR2,但其作用
星形胶质细胞表达的TNFR2在MS/EAE进展中的作用仍未解决。致病星形胶质细胞(A1)或
已经描述了神经保护/抗炎特性(A2);然而,
有害的和有益的星形胶质细胞的功能仍然不完全清楚。我们已经得到了令人振奋的初步结果
结果通过研究星形胶质细胞TNFR2的作用,支持其在抑制EAE进展中的核心作用
在人源化的转基因小鼠模型中表达人MS相关MHC II等位基因HLA-DR2b和TNFR2
缺乏TnFR2分子表达的小鼠,这里称为DR2BΔR2小鼠。这一模型提供了证据表明,人类白细胞抗原-
DR2b分子有利于Th17的发育,而阻碍Foxp3+Treg细胞的形成。重要的是,我们观察到
当中枢神经系统驻留细胞缺失时,DR2bΔR2小鼠发生进行性脑脊髓炎和星形胶质细胞增生症。
此外,在患有EAE的DR2bΔR2动物中,星形胶质细胞显示促炎症细胞因子和
CXCR5表达增加。此外,CXCL13在这些小鼠的中枢神经系统中表达上调,与以前的研究结果一致
报道称CXCL13的中枢神经系统表达可加重EAE并促进非EAE的慢性白质损害
依赖于外周CXCR5+白细胞的募集,而受损神经元表达的CXCL13可以
激活星形胶质细胞。此外,我们观察到在星形胶质细胞群体中,TNFR2的表达存在显著的二分性。
在患有EAE的DR2b小鼠中,表明TNFR2的表达可能有利于星形胶质细胞A2和A1亚群。因此,
我们的建议将检验中心假设,即星形胶质细胞中的TNFR2信号抑制神经炎症的进展
通过抑制致病和促进保护星形胶质细胞的功能。我们将通过以下方式测试我们的假设:(1)确定
TNFR2在抑制致病星形胶质细胞效应蛋白功能和阻止EAE进展中的作用;以及(2)测定
TNFR2调控的CXCL13/CXCR5信号在进展性EAE中对星形胶质细胞激活和功能的影响
在DR2BΔR2小鼠中。我们将通过应用创新的新方法来实现这项建议的目标,包括
我们的进展性EAE模型,开发了星形胶质细胞特异性的TNFR2和CXCR5基因敲除小鼠,并创新
免疫学和分子生物学方法,包括单细胞RNA-SEQ和RNAScope。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS G. FORSTHUBER其他文献
THOMAS G. FORSTHUBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS G. FORSTHUBER', 18)}}的其他基金
The role of TNFR2 in ameliorating progressive encephalomyelitis
TNFR2 在改善进行性脑脊髓炎中的作用
- 批准号:
10211348 - 财政年份:2021
- 资助金额:
$ 37.87万 - 项目类别:
The role of TNFR2 in ameliorating progressive encephalomyelitis
TNFR2 在改善进行性脑脊髓炎中的作用
- 批准号:
10331890 - 财政年份:2021
- 资助金额:
$ 37.87万 - 项目类别:
MIF inhibition as a novel treatment for autoimmune myocarditis
MIF 抑制作为自身免疫性心肌炎的新型治疗方法
- 批准号:
8793098 - 财政年份:2014
- 资助金额:
$ 37.87万 - 项目类别:
MIF inhibition as a novel treatment for autoimmune myocarditis
MIF 抑制作为自身免疫性心肌炎的新型治疗方法
- 批准号:
8679540 - 财政年份:2014
- 资助金额:
$ 37.87万 - 项目类别:
BIOMARKER DISCOVERY IN GLUCOCORTICOID RESISTANCE IN EAE
EAE 糖皮质激素耐药性生物标志物的发现
- 批准号:
8357130 - 财政年份:2011
- 资助金额:
$ 37.87万 - 项目类别:
Steroid resistance: Experimental Autoimmune Encephalomyelitis/Multiple Sclerosis
类固醇抵抗:实验性自身免疫性脑脊髓炎/多发性硬化症
- 批准号:
7912212 - 财政年份:2007
- 资助金额:
$ 37.87万 - 项目类别:
Steroid resistance: Experimental Autoimmune Encephalomyelitis/Multiple Sclerosis
类固醇抵抗:实验性自身免疫性脑脊髓炎/多发性硬化症
- 批准号:
7208702 - 财政年份:2007
- 资助金额:
$ 37.87万 - 项目类别:
Steroid resistance: Experimental Autoimmune Encephalomyelitis/Multiple Sclerosis
类固醇抵抗:实验性自身免疫性脑脊髓炎/多发性硬化症
- 批准号:
7585250 - 财政年份:2007
- 资助金额:
$ 37.87万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 37.87万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 37.87万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 37.87万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 37.87万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 37.87万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 37.87万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 37.87万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 37.87万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)














{{item.name}}会员




